Consensus Abbott Laboratories Kazakhstan S.E.

Stocks

ABT_KZ

US0028241000

Medical Equipment, Supplies & Distribution

End-of-day quote Kazakhstan S.E. 05/10/2026			5-day change	1st Jan Change
110.00 ^USD	0.00%		+4.76%	-23.61%

06/10	Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities	CI
06/10	Abbott Laboratories Receives FDA Approval to Include Interactive Features in CardioMEMS Heart Monitor	MT

ef1f79c2d3813a836a6eb6.FVloXy0ZvB8HEXpOtgS7odSLUd2N5UNhK9m_b8T6Edo.UwwlN30r9mpWYC8-82PJxL_iDuT9jHE1HY_lQpKZa6kiKQ4TWW_9aVVaPw~081abaf24566ba581df35f5ff9964a8f

Analysts' recommendations: Abbott Laboratories

05/10	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
21/08	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
13/08	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
29/07	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
28/07	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
23/07	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
22/07	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
18/07	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
17/07	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
17/07	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
17/07	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
17/07	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
17/07	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
17/07	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
17/07	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
06/07	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
01/07	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
12/06	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
27/05	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05/05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
22/04	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
ABBOTT LABORATORIES	-	-	-	-
ABBOTT LABORATORIES				+22.98%
MEDTRONIC PLC				+19.92%
STRYKER CORPORATION				+31.62%
ESSILORLUXOTTICA				+54.94%
CENCORA, INC.				+16.71%
HOYA CORPORATION				+19.37%
BECTON, DICKINSON AND COMPANY				+7.64%
IDEXX LABORATORIES, INC.				+36.07%
DEXCOM, INC.				+15.4%
Average				+24.96%
Weighted average by Cap.				+25.81%